SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-23-000065
Filing Date
2023-10-20
Accepted
2023-10-20 07:58:14
Documents
21
Period of Report
2023-10-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K angn-20231019.htm   iXBRL 8-K 25732
2 EX-10.1 elicio_therapeuticsx-xse.htm EX-10.1 3259
6 elicio_therapeuticsx-xse001.jpg GRAPHIC 224831
7 elicio_therapeuticsx-xse002.jpg GRAPHIC 302398
8 elicio_therapeuticsx-xse003.jpg GRAPHIC 300874
9 elicio_therapeuticsx-xse004.jpg GRAPHIC 314755
10 elicio_therapeuticsx-xse005.jpg GRAPHIC 262072
11 elicio_therapeuticsx-xse006.jpg GRAPHIC 245357
12 elicio_therapeuticsx-xse007.jpg GRAPHIC 278267
13 elicio_therapeuticsx-xse008.jpg GRAPHIC 129495
  Complete submission text file 0001601485-23-000065.txt   2996408

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20231019.xsd EX-101.SCH 1989
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20231019_lab.xml EX-101.LAB 25138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20231019_pre.xml EX-101.PRE 13130
15 EXTRACTED XBRL INSTANCE DOCUMENT angn-20231019_htm.xml XML 2816
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 231335981
SIC: 2834 Pharmaceutical Preparations